1. Home
  2. STTK vs KE Comparison

STTK vs KE Comparison

Compare STTK & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.90

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.82

Market Cap

586.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
KE
Founded
2016
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
586.4M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
STTK
KE
Price
$6.90
$24.82
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$10.00
$28.00
AVG Volume (30 Days)
1.8M
179.1K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
0.78
Revenue
$1,000,000.00
$1,486,727,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.57
P/E Ratio
N/A
$32.96
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$18.04
52 Week High
$8.33
$33.19

Technical Indicators

Market Signals
Indicator
STTK
KE
Relative Strength Index (RSI) 64.10 46.31
Support Level $5.81 $23.54
Resistance Level $7.68 $26.91
Average True Range (ATR) 0.58 1.16
MACD 0.28 0.00
Stochastic Oscillator 84.39 35.80

Price Performance

Historical Comparison
STTK
KE

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

Share on Social Networks: